PortfoliosLab logo

Aeglea BioTherapeutics, Inc. (AGLE)

Equity · Currency in USD · Last updated Jul 2, 2022

Company Info

ISINUS00773J1034
CUSIP00773J103
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.51
Year Range$0.51 - $8.42
EMA (50)$1.17
EMA (200)$3.52
Average Volume$788.53K
Market Capitalization$30.90M

AGLEShare Price Chart


Chart placeholderClick Calculate to get results

AGLEPerformance

The chart shows the growth of $10,000 invested in Aeglea BioTherapeutics, Inc. on Apr 8, 2016 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $522 for a total return of roughly -94.78%. All prices are adjusted for splits and dividends.


AGLE (Aeglea BioTherapeutics, Inc.)
Benchmark (^GSPC)

AGLEReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-67.72%-7.43%
6M-88.79%-19.95%
YTD-89.26%-19.74%
1Y-92.67%-10.99%
5Y-33.27%9.57%
10Y-37.76%10.64%

AGLEMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AGLESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aeglea BioTherapeutics, Inc. Sharpe ratio is -0.94. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


AGLE (Aeglea BioTherapeutics, Inc.)
Benchmark (^GSPC)

AGLEDividend History


Aeglea BioTherapeutics, Inc. doesn't pay dividends

AGLEDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AGLE (Aeglea BioTherapeutics, Inc.)
Benchmark (^GSPC)

AGLEWorst Drawdowns

The table below shows the maximum drawdowns of the Aeglea BioTherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aeglea BioTherapeutics, Inc. is 95.79%, recorded on Jun 30, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.79%Apr 11, 20161567Jun 30, 2022

AGLEVolatility Chart

Current Aeglea BioTherapeutics, Inc. volatility is 68.30%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AGLE (Aeglea BioTherapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Aeglea BioTherapeutics, Inc.


Loading data...